Clinical Trial Update: Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of LIM-0705 in subjects with impaired glucose tolerance or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Insulin Resistance

Drugs mentioned

• LIM-0705

Snippet

Sponsor: Limerick BioPharma | Conditions: Impaired Glucose Tolerance, Insulin Resistance | Phase 2 | Status: UNKNOWN